Cargando…

Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report

INTRODUCTION: Synthol injection for body contouring has been used by bodybuilders for some time. We report two extremely rare systemic complications; pulmonary granulomatosis and hypercalcemia, in a woman who has received Synthol injections for buttocks augmentation. PRESENTATION OF CASE: The case d...

Descripción completa

Detalles Bibliográficos
Autores principales: Alimoradi, Mersad, Chahal, Ahmad, El-Rassi, Elie, Daher, Karim, Sakr, Gazy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426527/
https://www.ncbi.nlm.nih.gov/pubmed/34522373
http://dx.doi.org/10.1016/j.amsu.2021.102771
_version_ 1783750059617157120
author Alimoradi, Mersad
Chahal, Ahmad
El-Rassi, Elie
Daher, Karim
Sakr, Gazy
author_facet Alimoradi, Mersad
Chahal, Ahmad
El-Rassi, Elie
Daher, Karim
Sakr, Gazy
author_sort Alimoradi, Mersad
collection PubMed
description INTRODUCTION: Synthol injection for body contouring has been used by bodybuilders for some time. We report two extremely rare systemic complications; pulmonary granulomatosis and hypercalcemia, in a woman who has received Synthol injections for buttocks augmentation. PRESENTATION OF CASE: The case discussed in this report is of a 36-year-old lady who presented for severe hypercalcemia and nephrocalcinosis. Subsequent workup revealed granulomas in the buttocks and in the lungs. Upon questioning, it was discovered that she had received Synthol injection for buttocks augmentation a few months earlier. Labs were consistent with calcitriol mediated hypercalcemia, a phenomenon observed in granulomatous diseases. A diagnosis of foreign body granulomatosis with pulmonary migration and secondary hypercalcemia was made. The patient was started on prednisone and showed an initial positive response. DISCUSSION: Reported complications of Synthol include pain, muscle deformity, and ulceration at the injection site. Hypercalcemia secondary to foreign body granulomatosis after Synthol injection has been reported only once previously, and here we report a second case. The hypercalcemia is thought to be calcitriol mediated, where overexpression of CYP27B1 in the macrophages forming the granulomas leads to pathological extrarenal calcitriol production. Pulmonary granulomatosis, theorized to be secondary to hematologic migration of the injected material, has never been reported previously with Synthol use. CONCLUSION: Synthol injection for body contouring may be a cause of extensive local and pulmonary foreign body granulomatosis leading to calcitriol mediated hypercalcemia. History of cosmetic injections should not be disregarded during history taking.
format Online
Article
Text
id pubmed-8426527
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84265272021-09-13 Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report Alimoradi, Mersad Chahal, Ahmad El-Rassi, Elie Daher, Karim Sakr, Gazy Ann Med Surg (Lond) Case Report INTRODUCTION: Synthol injection for body contouring has been used by bodybuilders for some time. We report two extremely rare systemic complications; pulmonary granulomatosis and hypercalcemia, in a woman who has received Synthol injections for buttocks augmentation. PRESENTATION OF CASE: The case discussed in this report is of a 36-year-old lady who presented for severe hypercalcemia and nephrocalcinosis. Subsequent workup revealed granulomas in the buttocks and in the lungs. Upon questioning, it was discovered that she had received Synthol injection for buttocks augmentation a few months earlier. Labs were consistent with calcitriol mediated hypercalcemia, a phenomenon observed in granulomatous diseases. A diagnosis of foreign body granulomatosis with pulmonary migration and secondary hypercalcemia was made. The patient was started on prednisone and showed an initial positive response. DISCUSSION: Reported complications of Synthol include pain, muscle deformity, and ulceration at the injection site. Hypercalcemia secondary to foreign body granulomatosis after Synthol injection has been reported only once previously, and here we report a second case. The hypercalcemia is thought to be calcitriol mediated, where overexpression of CYP27B1 in the macrophages forming the granulomas leads to pathological extrarenal calcitriol production. Pulmonary granulomatosis, theorized to be secondary to hematologic migration of the injected material, has never been reported previously with Synthol use. CONCLUSION: Synthol injection for body contouring may be a cause of extensive local and pulmonary foreign body granulomatosis leading to calcitriol mediated hypercalcemia. History of cosmetic injections should not be disregarded during history taking. Elsevier 2021-09-03 /pmc/articles/PMC8426527/ /pubmed/34522373 http://dx.doi.org/10.1016/j.amsu.2021.102771 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Alimoradi, Mersad
Chahal, Ahmad
El-Rassi, Elie
Daher, Karim
Sakr, Gazy
Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title_full Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title_fullStr Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title_full_unstemmed Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title_short Synthol systemic complications: Hypercalcemia and pulmonary granulomatosis. A case report
title_sort synthol systemic complications: hypercalcemia and pulmonary granulomatosis. a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426527/
https://www.ncbi.nlm.nih.gov/pubmed/34522373
http://dx.doi.org/10.1016/j.amsu.2021.102771
work_keys_str_mv AT alimoradimersad syntholsystemiccomplicationshypercalcemiaandpulmonarygranulomatosisacasereport
AT chahalahmad syntholsystemiccomplicationshypercalcemiaandpulmonarygranulomatosisacasereport
AT elrassielie syntholsystemiccomplicationshypercalcemiaandpulmonarygranulomatosisacasereport
AT daherkarim syntholsystemiccomplicationshypercalcemiaandpulmonarygranulomatosisacasereport
AT sakrgazy syntholsystemiccomplicationshypercalcemiaandpulmonarygranulomatosisacasereport